Indolent B-cell Non-hodgkin Lymphoma

• CLINICAL_TRIALS research · 2026-04-22
  Clinical Trial Update: Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma [Phase 2]

  Phase 2 trial evaluating reduced-dose radiotherapy for indolent B-cell non-Hodgkin lymphoma is currently recruiting.

• CLINICAL_TRIALS research · 2026-04-08
  Clinical Trial Update: First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma [Phase 1, Phase 2]

  Genmab-sponsored first-in-human trial in relapsed/refractory B-cell lymphomas spans Phase 1/2 and is currently active/not recruiting.

• CLINICAL_TRIALS research · 2025-09-25
  Clinical Trial Update: Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma [Phase 1]

  This Phase 1 trial evaluates low-dose radiation as bridging therapy for relapsed or refractory B-cell non-Hodgkin lymphomas, including DLBCL…

• CLINICAL_TRIALS research · 2025-04-24
  Clinical Trial Update: A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell NHL [Phase 1, Phase 2]

  This clinical trial update describes a Phase 1/2 study evaluating BI-1206 in combination with Rituximab with or without Acalabrutinib in sub…

• CLINICAL_TRIALS research · 2025-04-06
  Clinical Trial Update: Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies [Phase 1]

  Phase 1 study evaluating autologous CD19 CAR-T cell therapy SYNCAR-001 with orthogonal IL-2 STK-009 in CD19-positive hematologic malignancie…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2024-06-14
  Clinical Trial Update: Ga-68-CXCR4 PET/CT in Indolent B-cell Lymphoma [Phase 2]

  Phase 2 clinical trial evaluating Ga-68-CXCR4 PET/CT imaging in patients with indolent B-cell non-Hodgkin lymphoma, currently recruiting.